» Articles » PMID: 33374958

MHCII3D-Robust Structure Based Prediction of MHC II Binding Peptides

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2020 Dec 30
PMID 33374958
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Knowledge of MHC II binding peptides is highly desired in immunological research, particularly in the context of cancer, autoimmune diseases, or allergies. The most successful prediction methods are based on machine learning methods trained on sequences of experimentally characterized binding peptides. Here, we describe a complementary approach called MHCII3D, which is based on structural scaffolds of MHC II-peptide complexes and statistical scoring functions (SSFs). The MHC II alleles reported in the Immuno Polymorphism Database are processed in a dedicated 3D-modeling pipeline providing a set of scaffold complexes for each distinct allotype sequence. Antigen protein sequences are threaded through the scaffolds and evaluated by optimized SSFs. We compared the predictive power of MHCII3D with different sequence-based machine learning methods. The Pearson correlation to experimentally determine IC values for MHC II Automated Server Benchmarks data sets from IEDB (Immune Epitope Database) is 0.42, which is in the competitor methods range. We show that MHCII3D is quite robust in leaving one molecule out tests and is therefore not prone to overfitting. Finally, we provide evidence that MHCII3D can complement the current sequence-based methods and help to identify problematic entries in IEDB. Scaffolds and MHCII3D executables can be freely downloaded from our web pages.

Citing Articles

MHCII-peptide presentation: an assessment of the state-of-the-art prediction methods.

Yang Y, Wei Z, Cia G, Song X, Pucci F, Rooman M Front Immunol. 2024; 15:1293706.

PMID: 38646540 PMC: 11027168. DOI: 10.3389/fimmu.2024.1293706.


Immunogenicity Assessment of Therapeutic Peptides.

Li W, Wei J, Jiang Q, Zhou Y, Yan X, Xiang C Curr Med Chem. 2024; 31(26):4100-4110.

PMID: 38275064 DOI: 10.2174/0109298673264899231206093930.


Investigating the human and nonobese diabetic mouse MHC class II immunopeptidome using protein language modeling.

Hartout P, Pocuca B, Mendez-Garcia C, Schleberger C Bioinformatics. 2023; 39(8).

PMID: 37527005 PMC: 10421966. DOI: 10.1093/bioinformatics/btad469.


Immunoinformatics Approaches for Vaccine Design: A Fast and Secure Strategy for Successful Vaccine Development.

Rawat S, Keshri A, Kaur R, Prasad A Vaccines (Basel). 2023; 11(2).

PMID: 36851099 PMC: 9959071. DOI: 10.3390/vaccines11020221.

References
1.
Hamelryck T, Borg M, Paluszewski M, Paulsen J, Frellsen J, Andreetta C . Potentials of mean force for protein structure prediction vindicated, formalized and generalized. PLoS One. 2010; 5(11):e13714. PMC: 2978081. DOI: 10.1371/journal.pone.0013714. View

2.
Davies M, Sansom C, Beazley C, Moss D . A novel predictive technique for the MHC class II peptide-binding interaction. Mol Med. 2004; 9(9-12):220-5. PMC: 1430983. DOI: 10.2119/2003-00032.sansom. View

3.
Bordner A . Towards universal structure-based prediction of class II MHC epitopes for diverse allotypes. PLoS One. 2010; 5(12):e14383. PMC: 3004863. DOI: 10.1371/journal.pone.0014383. View

4.
Jensen K, Andreatta M, Marcatili P, Buus S, Greenbaum J, Yan Z . Improved methods for predicting peptide binding affinity to MHC class II molecules. Immunology. 2018; 154(3):394-406. PMC: 6002223. DOI: 10.1111/imm.12889. View

5.
Nielsen M, Lundegaard C, Lund O . Prediction of MHC class II binding affinity using SMM-align, a novel stabilization matrix alignment method. BMC Bioinformatics. 2007; 8:238. PMC: 1939856. DOI: 10.1186/1471-2105-8-238. View